Table 3 Clinical characteristics in hospitalized cancer patients with severe ALQTS between Non-survivors and survivors
From: Hospitalized cancer patients with acquired long QT syndrome-a matched case-control study
Parameters | Non-survivors (n = 95) | Survivors (n = 55) | P Value |
|---|---|---|---|
Age, years | 66 ± 10 | 56 ± 14 | 0.000 |
≥ 70 years | 36.8% | 18.2% | 0.016 |
Gender | |||
Female | 49.5% | 72.7% | 0.005 |
Male | 50.5% | 27.3% | |
HR, bpm | 90 ± 19 | 85 ± 12 | 0.062 |
QTc, ms | 513 | 509 | 0.243 |
Hypokalemia | 40.4% | 17% | 0.004 |
Hypocalcaemia | 26.1% | 17% | 0.209 |
Use of QT-prolonging drugs | 36.4% | 28.4% | 0.312 |
Renal insufficiency | 8.4% | 0.0% | 0.027 |
Infection | 26.3% | 12.7% | 0.05 |
Anemia | 15.8% | 5.5% | 0.061 |
Arrhythmia | 5.3% | 9.1% | 0.365 |
Heart Failure | 7.4% | 5.5% | 0.651 |
Hypertension | 29.5% | 29.1% | 0.96 |